Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1β and sCD200 in cases of Samter's syndrome: 36 months follow-up

Immunopharmacology and Immunotoxicology

Volumn 35, Issue 4, 2013, Pages 524-527

  Yalcin, Arzu Didem ^a   Uçar, Seçil ^b   Gumuslu, Saadet ^c   Strauss, Ludwig G ^d  

^a MH Antalya Training and Research Hospital   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

^c AKDENIZ UNIVERSITY   (Turkey)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

25 hydroxyvitamin D; Anti IgE; Aspirin induced asthmatic patients; Eosinophil cationic peptide; Fractional exhale nitric oxide concentrations; IL 1 ; Omalizumab; Samter's syndrome; Soluble CD200

Indexed keywords

25 HYDROXYVITAMIN D; ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CD200 ANTIGEN; EOSINOPHILIC CATIONIC PEPTIDE; FLUTICASONE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 1BETA; METHYLPREDNISOLONE; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OMALIZUMAB; PROTEIN; SALMETEROL; STEROID; UNCLASSIFIED DRUG;

ADULT; ALLERGIC ASTHMA; ALLERGY; ANAPHYLAXIS; ARTICLE; CASE REPORT; COUGHING; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFECT; DYSPNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; FOLLOW UP; HUMAN; IMMUNOASSAY; INFLAMMATION; LUNG FUNCTION TEST; MALE; MEDICAL HISTORY; NOSE POLYP; PATHOGENESIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SAMTER SYNDROME; SNEEZING; SYMPTOM; TREATMENT OUTCOME;

ADULT; ANTI-ALLERGIC AGENTS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIGENS, CD; ASPIRIN; ASTHMA; DRUG HYPERSENSITIVITY; EOSINOPHIL CATIONIC PROTEIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; NASAL POLYPS; SYNDROME; VITAMIN D;

EID: 84880285814     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2013.811598     Document Type: Article

References (25)

1. Zeitz HJ. Bronchial asthma, nasal polyps, and aspirin sensitivity: Samter's syndrome. Clin Chest Med 1988; 9: 567-576.
2. Shen J, Peterson M, Mafee M, Nguyen QT. Aural polyps in Samter's triad: case report and literature review. Otol Neurotol 2012; 33: 774-778.
3. Onerci M, Elsurer C, Guzel EE, Dagdeviren A. Distribution of inflammatory cells, adhesion molecules, intermediate filaments, and chemokine receptors in subgroups of nasal polyp patients. Am J Rhinol Allergy 2011; 25: 176-180.
4. Amar YG, Frenkiel S, Sobol SE. Outcome analysis of endoscopic sinus surgery for chronic sinusitis in patients having Samter's triad. J Otolaryngol 2000; 29: 7-12.
5. Mendelsohn D, Jeremic G, Wright ED, Rotenberg BW. Revision rates after endoscopic sinus surgery: a recurrence analysis. Ann Otol Rhinol Laryngol 2011; 120: 162-166.
6. Kim JE, Kountakis SE. The prevalence of Samter's triad in patients undergoing functional endoscopic sinus surgery. Ear Nose Throat J 2007; 86: 396-399.
7. Chang TW, Shiung YY. Anti IgE as a mast cell stabilizing therapeutic agent. J Allergy Clin Immunol 2006; 117: 1203-1212.
8. Chang TW. The pharmacological basis of anti-IgE therapy. Nat Biotechnol 2000; 18: 157-162.
9. Noga O, Hanf G, Brachmann I, et al. Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma. J Allergy Clin Immunol 2006; 117: 1493-1499.
10. Yalcin AD, Bisgin A, Gorczynski RM. IL-8, IL10, TGF-b and GCSF levels were increased in severe persistent allergic asthma patients with the anti-IgE treatment. Mediators Inflammation 2012; 2012: Article ID 720976. doi: 10.1155/2012/720976.
11. Yalcin AD, Gumuslu S, Parlak GE, et al. Systemic levels of ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis. Immunopharmacol Immunotoxicol 2012; 34: 1047-1053.
12. Yalcin AD, Gorczynski RM, Parlak GE, et al. Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment. Clin Lab 2012; 58: 89-96.
13. Awad OG, Lee JH, Fasano MB, Graham SM. Sinonasal outcomes after endoscopic sinus surgery in asthmatic patients with nasal polyps: a difference between aspirin-tolerant and aspirin-induced asthma? Laryngoscope 2008; 118: 1282-1286.
14. Yalcin AD, Gorczynski RM, Cilli A, Straus L. Omalizumab (anti-IgE) therapy increases blood glucose levels in severe persistent allergic asthma patients with diabetes mellitus: 18 months follow-up. Clin Lab, in press.
15. Global Initiative for Asthma: GINA Report, Global Strategy for Asthma Management and Prevention-updated 2006. 2006. Available from: www.ginasthma.org
16. Roca J, Sanchis J, Agusti-Vidal A. Spirometric reference values from a Mediterranean population. Clin Respir Physiol 1986; 22: 217-224.
17. Kim CK. Eosinophil-derived neurotoxin: a novel biomarker for diagnosis and monitoring of asthma. Korean J Pediatr 2013; 56: 8-12.
18. Scott S, Currie J, Albert P, et al. Risk of misdiagnosis, healthrelated quality of life, and BMI in patients who are overweight with doctor-diagnosed asthma quality of life in obese patients with asthma. Chest 2012; 141: 616-624.
19. Yalcin AD, Karakas AA, Soykam G, et al. A case of toxic epidermal necrolysis with diverse etiologies: successful treatment with intravenous immunoglobulin and pulse prednisolone and effects on sTRAIL and sCD200 levels. Clin Lab 2013; 59: 681-685.
20. Gorczynski RM. CD200: CD200R-mediated regulation of immunity. ISRN Immunol 2012; 2012: Article ID 682168. doi: 10.5402/2012/682168.
21. Norton R, O'Connell MA. Vitamin D: potential in the prevention and treatment of lung cancer. Anticancer Res 2012; 32: 211-221.
22. Korn S, Hubner M, Jung M, et al. Severe and uncontrolled adult asthma is associated with vitamin D insufficiency and deficiency. Respir Res 2013; 14: 25. doi: 10.1186/1465-9921-14-25.
23. Krause K, Metz M, Makris M, et al. The role of interleukin-1 in allergy-related disorders. Curr Opin Allergy Clin Immunol 2012; 12: 477-484.
24. Gevaert P, Calus L, Van Zele T. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol 2013; 131: 110-116.
25. Scadding GK, Gray P, Belvisi MG, Mitchell JA. High levels of nitric oxide synthase activity are associated with nasal polyp tissue from aspirin-sensitive asthmatics. Acta Otolaryngol 2002; 122: 302-305.